submit to the journals

-Macular Degeneration Journal Articles, Videos And Insights

-Macular Degeneration:FEATURED Articles

flipper_slider

-Macular Degeneration: Latest Articles

-Macular Degeneration: INSIGHTS

The touchOPHTHALMOLOGY website provides a selection of resources to inform clinicians and patients about the latest developments in the field. The following are quick, non peer-reviewed, opinion-based updates addressing current trends and opinion on the most recent advances in the area of ophthalmology:

Insight
Novel therapeutic targets in wet AMD Katrina Mountfort, PhD, Freelance Medical Writer, York, UK
Insight
EURETINA 2018 – Macula Society Symposium: The Most Exciting Developments in Retina Vanessa Lane, PhD, Senior Medical Writer, Touch Medical Media, UK
Heather Hall, Associate Editor, touchOPHTHALMOLOGY, UK

-Macular Degeneration:FEATURED VIDEOS

Editor's choice

Baruch Kuppermann discusses the challenges of treating patients with dry AMD. Unlike wet AMD, which is responsive to anti-VEGF therapy, there are multiple challenges with wet AMD including the complement pathway and neuroprotection. There is an ongoing search into new ways of tracking wet AMD to find appropriate endpoints for clinical trials. KEYWORDS: wet AMD, age-related macular degeneration, complement pathway, drusen, geographic atrophy, clinical trials, neuroprotection, autoflorescence, efficacy end-points, microperimetry
Growing old leads to a growing number of health problems, including those that challenge our ability to see. Age-related macular degeneration (AMD) is a disease that -- until recently -- robbed the elderly of the ability to read, drive and see the faces of their loved ones. Thanks to the invention of OCT, doctors can catch the disease before vision is lost. And with the aid of new drugs, AMD can be stopped in its tracks. This video has been included in our media gallery with permission from ARVO. For more information about ARVO please visit: www.arvo.org

-Macular Degeneration:Latest Videos

Video List based on Category on Node Page

Latest Videos

The ARIES trial compares an early versus a late start for a Treat-and-Extend (T&E) regimen, an increasingly popular approach to treatment worldwide, for wet or neovascular age-related macular degeneration (AMD). Professor Paul Mitchell gives an overview of the study, and then goes on to discuss...
The advent of new imaging modalities has greatly aided the understanding of neovascular age-related macular degeneration (AMD). Dr Roberto Gallego-Pinazo claims that much of this progress can be attributed to structural optical coherence tomography (OCT). In this interview, filmed at AAO 2018, Dr...
At this year’s EURETINA congress, we caught up with Dr Pravin Dugel to discuss neovascular age-related macular degeneration (nAMD). Dr Dugel suggests that while there have been recent advances in the treatment of nAMD, there is still a need to obtain better efficacy and find drugs that maintain...
Hemal Mehta speaks to us about the current management options for wet age-related macular degeneration (AMD), including intravitreal injections of anti-VEGF agents and other injection-based therapy, and their treatment burden. He then discusses the new PanOptica Eye Drop, a topical treatment for...
Baruch Kuppermann discusses the challenges of treating patients with dry AMD. Unlike wet AMD, which is responsive to anti-VEGF therapy, there are multiple challenges with wet AMD including the complement pathway and neuroprotection. There is an ongoing search into new ways of tracking wet AMD to...
Pravin Dugel discusses his highlights from EURETINA 2017.

LATEST TWEETS

Conference Highlights